Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
To study the effectiveness of an immunosuppressive drug sirolimus, in the treatment of
chronic graft versus host disease in combination with prednisone.